GNAS mutations have been previously associated with cystic pancreatic neoplasms, especially intraductal papillary mucinous neoplasms (IPMN), acting as cancer initiating drivers and being conserved between precursor lesions and transformed malignant tumors [35]. The gene discussed is GNAS; the disease is pancreatic intraductal papillary-mucinous neoplasm.